← Leaderboards
Irfan Khan
Georgetown University
$220,618
Attributed
$220,618
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.7K · FY2019–23$100K$75K$50K$25K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$220,618 · 1
By mechanism
F30$220,618 · 1
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Robert B. Dickson$4,932,182
- Careen K Tang$2,470,359
- Susette C Mueller$4,209,997
- Hongfang Liu$19,184,300
- Anton Wellstein$12,396,274
Others in their field
Other Emerging Leaders on “Aging”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$64,693,871
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$25,556,733
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,272,240
- Abraham Aizer Brody · New York University School Of Medicine$23,963,022
Research focus
AgingAffectAp20187ApoptosisAnti-Pd-1Bone Marrow CellsBone Marrow TransplantationBreast Cancer CellBreast Cancer ProgressionBreast Cancer TreatmentCancer TherapyCasp8 GeneCause Of DeathCdkn2a GeneCell AgingCell CycleCell Cycle ArrestCell InjuryCellsCell TypeCheckpoint InhibitionChronicClinical TrialsCytokine
Grant awards (5)
Impact of local and systemic cellular senescence toward Triple Negative Breast Cancer growth and drug therapy$52,694
F30 · FY2023 · CA · contact PI
Impact of local and systemic cellular senescence toward Triple Negative Breast Cancer growth and drug therapy$51,752
F30 · FY2022 · CA · contact PI
Impact of local and systemic cellular senescence toward Triple Negative Breast Cancer growth and drug therapy$51,036
F30 · FY2021 · CA · contact PI
Impact of local and systemic cellular senescence toward Triple Negative Breast Cancer growth and drug therapy$32,820
F30 · FY2020 · CA · contact PI
Impact of local and systemic cellular senescence toward Triple Negative Breast Cancer growth and drug therapy$32,316
F30 · FY2019 · CA · contact PI